Xenon pauses depression trial enrollment
Xenon Pharmaceuticals (NASDAQ:XENE) shares declined after the company temporarily paused new patient enrollment in clinical studies evaluating its drug candidate for major depression and bipolar depression.

Finance journalist at Grafa with years of experience covering Asia-Pacific financial markets at S&P Global, Mortgage Ezy, and GMA Network.
Xenon Pharmaceuticals (NASDAQ:XENE) shares declined after the company temporarily paused new patient enrollment in clinical studies evaluating its drug candidate for major depression and bipolar depression.
Brent crude and West Texas Intermediate oil prices declined for a third consecutive session as easing concerns over Saudi Arabian supply disruptions outweighed concerns about a wider Middle East conflict.
The Supreme Court of New South Wales extended Bathla Group's voluntary administration until Sept. 13, 2027.
BitGo Holdings has appointed Alex Rozman as chief compliance officer, effective September 21.
The Reserve Bank of Australia warned that high demand for data centres is pushing up global inflation alongside the ongoing Middle East conflict.
Stellar has activated Protocol 28 after a scheduled mainnet vote, adding infrastructure designed for larger smart-contract deployments.
CleanSpark has proposed $2.227 billion in senior secured notes to fund its Sandersville data centre.
Neu Horizon Uranium (ASX:NHU) completed its summer field campaign across the Arvidsjaur, Sorsele, and Vilhelmina uranium projects in Sweden.
Livium (ASX:LIT) announced that its insurer settled the final legal claim tied to a January 2019 fire at Envirostream Australia’s former Campbellfield site.
PROSPER has launched Performance Markets on Pharos Network, linking onchain strategy data with separately priced crypto assets.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy